Baker Brothers Advisors - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$95,511,286
-10.1%
20,763,323
+26.2%
0.55%
-10.6%
Q2 2023$106,268,163
+34.9%
16,450,180
+57.4%
0.62%
+43.4%
Q1 2023$78,794,357
-25.6%
10,450,1800.0%0.43%
-32.5%
Q4 2022$105,860,323
+2.4%
10,450,1800.0%0.64%
-6.1%
Q3 2022$103,352,000
-7.1%
10,450,1800.0%0.68%
+7.3%
Q2 2022$111,294,000
+9.2%
10,450,1800.0%0.63%
+7.9%
Q1 2022$101,889,000
-31.8%
10,450,1800.0%0.58%
-19.5%
Q4 2021$149,438,000
-28.6%
10,450,1800.0%0.73%
-21.0%
Q3 2021$209,422,000
-8.9%
10,450,1800.0%0.92%
-8.9%
Q2 2021$229,904,000
-35.2%
10,450,1800.0%1.01%
-34.4%
Q1 2021$354,888,000
-15.6%
10,450,1800.0%1.54%
-2.8%
Q4 2020$420,515,00010,450,1801.58%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$17,358,23889.37%
Founders Fund Growth Management, LLC 407,017$1,872,2785.10%
Prosight Management, LP 2,446,000$11,251,6003.57%
Intellectus Partners, LLC 876,633$4,032,5111.28%
Belmont Capital, LLC 510,000$2,346,0001.27%
Casdin Capital, LLC 2,360,129$10,856,5931.20%
GUARDIAN CAPITAL ADVISORS LP 1,786,414$7,842,3570.88%
Baker Brothers Advisors 20,763,323$95,511,2860.55%
BRANDYWINE MANAGERS, LLC 56,976$262,0900.44%
Orbimed Advisors 4,180,768$19,231,5330.41%
View complete list of ABCELLERA BIOLOGICS INC shareholders